8款药品注册申请拟纳入优先审评

2019-04-01 佚名 中国药审

2019年3月29日,药审中心公示的拟优先审评的药品品种新增“盐酸安非他酮缓释片”等,公示期间如有异议,可在药审中心网站“信息公开-->优先审评公示-->拟优先审评品种公示”栏目下提出异议。

2019年3月29日,药审中心公示的拟优先审评的药品品种新增“盐酸安非他酮缓释片”等,公示期间如有异议,可在药审中心网站“信息公开-->优先审评公示-->拟优先审评品种公示”栏目下
提出异议。







版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1634766, encodeId=b1641634e66ee, content=<a href='/topic/show?id=6da725e314e' target=_blank style='color:#2F92EE;'>#优先审评#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25731, encryptionId=6da725e314e, topicName=优先审评)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4be222283241, createdName=ms5822920152752585, createdTime=Sat Jun 29 15:22:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1440620, encodeId=e20c1440620eb, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87444, encryptionId=eeeb8e444e6, topicName=药品注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3f64741524, createdName=1508842480_96220438, createdTime=Wed Apr 03 05:22:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556855, encodeId=6e3115568550e, content=<a href='/topic/show?id=e4016495635' target=_blank style='color:#2F92EE;'>#注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64956, encryptionId=e4016495635, topicName=注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c52c14833361, createdName=zhyy93, createdTime=Wed Apr 03 05:22:00 CST 2019, time=2019-04-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1634766, encodeId=b1641634e66ee, content=<a href='/topic/show?id=6da725e314e' target=_blank style='color:#2F92EE;'>#优先审评#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25731, encryptionId=6da725e314e, topicName=优先审评)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4be222283241, createdName=ms5822920152752585, createdTime=Sat Jun 29 15:22:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1440620, encodeId=e20c1440620eb, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87444, encryptionId=eeeb8e444e6, topicName=药品注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3f64741524, createdName=1508842480_96220438, createdTime=Wed Apr 03 05:22:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556855, encodeId=6e3115568550e, content=<a href='/topic/show?id=e4016495635' target=_blank style='color:#2F92EE;'>#注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64956, encryptionId=e4016495635, topicName=注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c52c14833361, createdName=zhyy93, createdTime=Wed Apr 03 05:22:00 CST 2019, time=2019-04-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1634766, encodeId=b1641634e66ee, content=<a href='/topic/show?id=6da725e314e' target=_blank style='color:#2F92EE;'>#优先审评#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25731, encryptionId=6da725e314e, topicName=优先审评)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4be222283241, createdName=ms5822920152752585, createdTime=Sat Jun 29 15:22:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1440620, encodeId=e20c1440620eb, content=<a href='/topic/show?id=eeeb8e444e6' target=_blank style='color:#2F92EE;'>#药品注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87444, encryptionId=eeeb8e444e6, topicName=药品注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3f64741524, createdName=1508842480_96220438, createdTime=Wed Apr 03 05:22:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556855, encodeId=6e3115568550e, content=<a href='/topic/show?id=e4016495635' target=_blank style='color:#2F92EE;'>#注册#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64956, encryptionId=e4016495635, topicName=注册)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c52c14833361, createdName=zhyy93, createdTime=Wed Apr 03 05:22:00 CST 2019, time=2019-04-03, status=1, ipAttribution=)]
    2019-04-03 zhyy93

相关资讯

国家药监局公布36批次药品不合格

2019年3月22日,国家药品监督管理局发布《关于31批次药品不符合规定的通告(2018年第53号)》。通告称,经江西省药品检验检测研究院等4家药品检验机构检验,标示为南京白敬宇制药有限责任公司等16家企业生产的36批次药品不符合规定。

这些药,开始大降价

海外原研药企若想保有一定量的中国市场,进口药价势必会维持较低的水平,甚至进一步下调。

2018年 阿尔茨海默病领域的10大重磅交易

全球大约有几千万名的阿尔茨海默病患者。阿尔茨海默病患者的两大重要病理特征为大脑中的淀粉样蛋白(Aβ)沉积和神经细胞中tau蛋白聚集导致的神经原纤维缠结。

11城药品集中采购试点全面落地,25种药品平均降价超一半

据中国之声《新闻和报纸摘要》报道,今年初,国办印发《国家组织药品集中采购和使用试点方案》,选择北京、天津、上海、重庆、沈阳、大连、厦门、广州、深圳、成都和西安11个城市开展试点工作。截至目前,11个城市均已明确具体执行时间与细则,药品带量采购相继落地,25种药品平均降价52%。这次降价药品主要针对高血压、抑郁症、乙肝、肺癌等需要长期用药的慢性疾病,价格平均降幅在52%,最高降幅达96%。西安交通大

11个药停止供货

日前,深圳全药网发布《关于公示4+7城市药品集中采购非中选药品深圳地区调整结果的通知》。

114药品大降价

昨日(3月26日),四川省药械招标采购服务中心发布《关于对国家组织药品集中采购非中选药品价格调整的通知》。